ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Get Free Report) has earned an average rating of “Buy” from the seven analysts that ...
Scotiabank analyst Louise Chen initiated coverage of ARS Pharmaceuticals (SPRY) with an Outperform rating and $30 price target The firm says ...
It was not until February 22, 2024, that another American-built spacecraft made a soft landing on the Moon. This was the Nova ...
We got the disappointing news that Marvel Studios has decided to hit pause on three prospective Disney+ shows earlier today, and based on these new details, Nova ...
Condé Nast and other news publishers involved in the lawsuit have licensed their content to other AI companies, such as OpenAI. But OpenAI also stands accused of using news articles without permission ...
It’s a city unlike anything you’ve seen before, and the people are undoubtedly unique, especially the person you meet to kick off the Ars Dimicatoria quest. Close to the north side of ...
Nova Lake, as it’s currently codenamed, is reportedly out with developers at this time while Intel refines and polishes it ahead of wider production. They might be a way off yet, but if you’re ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results